nuclear receptor subfamily 3 group C member 2
| GO Term | Evidence Code | PMID |
|---|---|---|
| regulation of DNA-templated transcription |
|
|
| regulation of transcription, DNA-templated |
|
|
| regulation of transcription by RNA polymerase II |
|
|
| signal transduction |
|
|
| nuclear receptor-mediated steroid hormone signaling pathway |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| nucleoplasm |
|
|
| nucleoplasm |
|
|
| cytoplasm |
|
|
| endoplasmic reticulum membrane |
|
|
| cytosol |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| DNA-binding transcription factor activity, RNA polymerase II-specific |
|
|
| DNA-binding transcription factor activity |
|
|
| DNA-binding transcription factor activity |
|
|
| nuclear steroid receptor activity |
|
|
| nuclear steroid receptor activity |
|
| Gene Ontology |
|---|
| estrogen response element binding |
| intracellular steroid hormone receptor signaling pathway |
| metal ion binding |
| sequence-specific DNA binding |
| zinc ion binding |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:4479 | pseudohypoaldosteronism | |
| DOID:0060855 | autosomal dominant pseudohypoaldosteronism type 1 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026